A Mixed Study on Doping Behaviour Amongst Malaysian Athletes in Individual Sports
By
Investigateur principal
E.
Koh
Universiti Putra Malaysia
Malaisie
―
2023
―
En vigueur
Sommaire
This study aims to achieve that via a mixed-method study that includes a quantitative knowledge, attitude and perspective survey (KAP) of athletes from bodybuilding, cycling, weightlifting, athletics, aquatics and qualitative study involving interviewing past athletes that were sanctioned in the past in these sports. The data collected from the study will be analyzed and interpreted for future doping interventions within the country.
Sport motivation, moral decision-making and attitudes doping of secondary school athletes in East Africa
By
Investigateur principal
E.
Rintaugu
Kenyatta University
Kenya
―
2023
―
En vigueur
Sommaire
This study will examine the sport motivation, moral decision-making, and attitudes towards doping among secondary school athletes in East Africa. The specific objective will be to find out the possible associations between sport motivation, moral decision[1]making, and attitudes towards doping.
Understanding (non)-adherence to the World Anti-Doping Code in athletics: Building capacity and amplifying voices in Ethiopia and Kenya
By
Investigateur principal
L.
Patterson
Leeds Beckett University
Royaume-Uni
―
2023
―
En vigueur
Sommaire
The project aims to aid AIU by investigating (non-) adherence to the World Anti[1]Doping Code (WADC) in Kenya and Ethiopia through a systematic consideration of the lived experience of athletes, athlete support personnel (ASP) and anti[1]doping/sporting organization staff. By amplifying African voices in track and field and road running, this project will offer unique insights into geographical regions that are under-served in anti-doping research.
An empirical investigation of moral values and attitudes in the context of clean sport behaviors
By
Investigateur principal
L.
Lazuras
Sheffield Hallam University
Royaume-Uni
―
2023
―
En vigueur
Sommaire
The project aims to advance scientific knowledge and understanding about the role of sport-specific values in fostering moral attitudes and emotions towards doping, and accordingly inform values-based education practices. The project’s objective is to adapt the Values & Moral Attitudes Model.
The role of coaches and parents in promoting anti-doping among the youth in grassroot sports in Kenya
By
Investigateur principal
J.
Kamenju
University of Nairobi
Kenya
―
2023
―
En vigueur
Sommaire
The study will examine the role of coaches and parents in promoting anti–doping behaviors among the youth in grassroots sports, investigating knowledge, attitudes of this population, while also exploring predictive factors of doping that can be influenced by education programs.
A qualitative exploration of athletes' lives, support needs and solutions after an anti-doping violation
By
Investigateur principal
C.
Blank
UMIT TIROL
Autriche
―
2023
―
En vigueur
Sommaire
A two-phase project examining athletes' experiences following an Adverse Analytical Finding and Anti-Doping Rule Violation. Phase one will use athlete researchers to interview sanctioned athletes. The results will inform phase two, a community based Participatory Research (CBPR) approach discuss how the relationship of sanctioned athletes to sport, clean sport and anti-doping is shaped and how rehabilitation and space for reparation can be incorporated into anti-doping.
Tramadol excretion study administered orally for the improvement of detection of these substances in anti-doping controls (analytical part)
By
Investigateur principal
R.
Ventura
Institut Municipal d’Investigacio Medica (IMIM)
Espagne
―
2022
―
En vigueur
Sommaire
Code: T22M01RTRV - Part 2
12 hours starting from any dose”, which is considered as the cut-off between maximal therapeutic dosagesfor athletes benefiting from a therapeutic use exemption and doses at which a doping effect could begin to be expected from systemic exposure [8]. The WADA established a urinary concentration
Tramadol excretion study administered orally for the improvement of detection of these substances in anti-doping controls (clinical part)
By
Investigateur principal
R.
de la Torre
Institut Municipal d’Investigacio Medica (IMIM)
Espagne
―
2022
―
En vigueur
Sommaire
Code: T22M01RTRV - Part 1
Salbutamolwas included in the prohibited list of the World Anti-Doping Agency (WADA) in 2004. While systemic salbutamol is banned, inhaled salbutamol is permitted but with dosage regimen restrictions. The dose should indeed not exceed “1600 µg over 24 hours in divided doses not to exceed 800 µg over.